AMBS - Most undervalued bio-tech in the market. Read the recent Yahoo news.
Expected to announce a deal soon with Becton Dickinson for its diagnostic test to detect early stage Alzheimer's. Potential $500,000,000 annual market.
Company's patented drug, MANF, could be the blockbuster drug of the 21st century. Due diligence.
Current market cap: $29M
Under a dime a share currently.
Follow the company on Twitter: @AmarantusBio .... 8,542 followers